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Background:  Perfluoroalkyl compounds (PFCs) are chemicals used to make coatings that resist 
stains, grease and water. Human exposure occurs via contaminated air, food and water. 
Previous analyses have reported an inverse association between prenatal PFC serum 
concentrations and birth weight.  
Methods:  Data from a prospective birth cohort study, the Avon Longitudinal Study of Parents 
and Children in the United Kingdom, was used to examine the association between in utero 
PFC exposure and body fatness in girls at age 9 years. Maternal serum samples, collected 
during pregnancy in 1991–1992, were analyzed for perfluorooctane sulfonate (PFOS), 
perfluorooctanoate (PFOA), perfluorohexane sulfonate (PFHxS) and perfluorononanoate 
(PFNA).  Body composition at age 9 was measured by dual x-ray emission absorptiometry 
(DXA) and percent total body fat (%BF) calculated. Multivariable linear regression was used to 
model associations between each PFC and %BF after adjustment for covariates including 
mothers’ educational status, pre-pregnancy body mass index and smoking (for PFNA only).   
Results:  Among 359 girls, median (intra-quartile range – IQR) %BF was 27.5 (IQR 21.7-34.6).  
Median (IQR) concentrations (all ng/ml) were 3.7 (2.9-4.8) for PFOA, 19.8 (15.0-25.3) for PFOS, 
1.6 (1.3-2.2) for PFHxS, and 0.5 (0.4-0.7) for PFNA. In the main effects models, maternal PFC 
concentrations were not significantly associated with daughters’ %BF; however, we observed 
some differences in the associations between maternal PFC concentrations and daughters’ 
%BF by mothers’ educational status. For PFHxS, %BF significantly increased by 3.0% (p=0.04) 
and 3.3% (p=0.03) for each one unit (ng/ml) increase among girls with mothers in the highest 
and middle education groups, respectively, but decreased by 3.1% (p=0.04) for the 
corresponding change among girls with mothers in the lowest education group. Similar results 
were observed for PFOS and PFOA.   
Conclusions:  Prenatal exposure to some PFCs was associated with increased body fatness in 




In 2012, the prevalence of overweight and obesity among girls aged 2-10 years in the United 
Kingdom (UK) was estimated at 22.8% (1, 2). Increased dietary energy intakes and sedentary 
behaviors conducive to positive energy balance are well-known risk factors for obesity. 
Emerging evidence suggests that there may also be mechanisms through which early life (e.g., 
in utero, infancy) exposure to a subclass of environmental endocrine-disrupting chemicals 
(EDCs) may contribute to altered growth and development with long-term effects on recognized 
risk factors for chronic disease (3-5). For example, certain EDCs could disrupt hormonally 
regulated ingestive behaviors or metabolic sequelae resulting in a metabolic phenotype with a 
predisposition to gain weight (4). Excess weight during childhood is associated with adverse 
effects on circulating blood lipids, measures of insulin resistance, and elevated blood pressure 
known to persist into adulthood and predict adult cardiometabolic risk factors and chronic 
disease (6-9).   
Perfluoroalkyl compounds (PFCs) are synthetically-made chemicals used as surfactants 
and surface coatings to decrease staining and sticking. PFCs are used commercially as 
lubricants, paper and textile coatings, in polishes, and in food packaging materials. Exposure to 
PFCs is widespread; detectable levels were found in more than 98% of Americans who 
participated in the U.S. National Health and Nutrition Examination Survey (NHANES) in 2003-
2004 (10). Because of their persistence and tendency to bioaccumulate, there is growing 
interest in the relationship between exposure to PFCs, especially during critical windows of 
susceptibility like early life, and health effects later on (11). Exposure to PFCs during 
development could permanently influence risk for chronic disease later in life through long-term 
effects on risk factors such as weight gain and body fatness (3).  
Prenatal exposure to PFCs has been linked with smaller size at birth (12-14).  In follow-
up analyses of girls at 20 months of age, those with higher prenatal serum concentrations of 
perfluorooctane sulfonate (PFOS) were heavier despite being smaller at birth (12). The goal of 
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the present research was to assess the role of prenatal exposure to PFCs on adiposity 
measured in older girls. Our analyses used existing prospectively collected data from the Avon 
Longitudinal Study of Parents and Children (ALSPAC) to evaluate the association between 
maternal prenatal serum concentrations of PFCs and body fatness measured by dual energy 
absorptiometry (DXA) in girls at age 9 years.  To date no other study has evaluated the 
association between prenatal PFC exposure and body composition measured by DXA in 




The ALSPAC is a prospective birth cohort in the United Kingdom (UK) that enrolled 14,541 
pregnant women residing in Avon, UK with expected delivery dates between April, 1991 and 
December, 1992 (15, 16). The goal of ALSPAC was to study the effects of genetics, lifestyle 
factors and the physical environment on the health, behavior and development of children. The 
current study includes a subset of mother-daughter dyads from the parent study selected for an 
ancillary study of maternal serum concentrations of environmental exposures and daughter’s 
puberty characteristics (17). To be considered, girls had to have at least two pubertal 
assessments to allow for classification of age at menarche. The ancillary study included all girls 
with early menarche (<11.5 years; n=218) and a random sample of girls without early menarche 
>11.5 years (n=230)). Informed consent was provided at the time of enrollment by the mothers. 
Human subjects’ protection and ethical approval was provided by the ALSPAC Law and Ethics 
Committee, the Local Research Ethics Committees and the Centers for Disease Control and 
Prevention (CDC) Institutional Review Board.          
Data Collection 
Mothers reported other demographic (e.g., age, educational status, race/ethnicity), health (e.g., 
prepregnancy body mass index - BMI kg/m2) and lifestyle (e.g., smoking status) information for 
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themselves at enrollment and later on for their children. Birth characteristics, including weight 
(grams), length (cm), and gestational age (wks) were abstracted from medical records. Since 
enrollment, detailed information has been collected on the children using parent or guardian- 
and self-reported questionnaires that address growth and development, psychological, social 
and health behaviors, and a variety of health-related outcomes. Trained research assistants 
reviewed these records with mothers as they were completed. In addition, periodic clinical 
assessments have collected detailed physiological data, cognitive information and biological 
samples (15, 18, 19).  Measures of total and regional body fat, lean mass and bone mass were 
made biennially using a Lunar Prodigy DXA scanner (GE Medical Systems Lunar, Madison, WI, 
USA) beginning at age 9 years. At age 9 a total of 359 girls whose mothers had provided 
prenatal sera for PFC measurements also contributed DXA scans for assessment of body 
fatness. The ALSPAC website contains details of all the data that are available through a fully 
searchable data dictionary available at: http://www.bris.ac.uk/alspac/researchers/data-
access/data-dictionary/. 
Laboratory Analyses 
At enrollment (1991–1992), mothers were asked to provide a single prenatal blood sample 
which was processed, frozen, and stored for later analysis. Median gestational age at collection 
was 15 weeks with an interquartile range of 10-28 weeks.  Perfluorooctanoate (PFOA), 
perfluorooctane sulfonate (PFOS), perfluorohexane sulfonate (PFHxS) and perfluorononanoate 
(PFNA) were measured in 448 stored maternal serum samples from mothers of girls by the 
National Center for Environmental Health laboratories of the CDC (Atlanta, GA) as described 
elsewhere (12). Briefly, sera samples were analyzed by on-line solid phase extraction coupled 
to isotope dilution high-performance liquid chromatography-tandem mass spectrometry. The 
limit of detection for PFNA was 0.08 ng/mL, for PFOA and PFHxS, 0.10 ng/mL and for PFOS 
0.20 ng/mL. Laboratory analyses included low-concentration and high-concentration pooled 
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standards, reagent blanks, and study samples. Precision of the measurements for the four 
PFCs was 8–13%.   
Statistical Analyses 
The laboratory data were plotted and examined for outliers. Measures of central tendency and 
distributions were calculated for demographic characteristics of the mother-daughter dyads. Our 
analyses were conducted on a sample of girls previously selected for a nested case-control 
study to evaluate the association of PFCs with early age at menarche. PFC concentrations did 
not appear to be associated with age at menarche in this sample (17); however, to account for 
the sampling selection probabilities we conservatively constructed stratum-weighted linear 
regression models to account for the sampling scheme used for participant selection, weighting 
(weight=15.1) the girls who attained menarche at 11.5 years or older (a random sample of the 
girls who attained menarche > 11.5 years of age). These regression models were used to 
evaluate the associations of girls’ body fatness (%BF) at 9 years of age with each PFC after 
adjustment for maternal pre-pregnancy BMI (continuous) and educational status (low, medium, 
high). In this analysis, not attaining any General Certificates of Secondary Education (GCSEs, 
at 16 years of age) was coded as “low” educational status, obtaining GCSEs as “medium” and 
completing GCSEs with additional education (e.g., University) was considered “high.”  PFNA 
models were also adjusted for maternal smoking status (yes/no any prenatal). A number of 
other potential confounders were considered including maternal age (continuous), race 
(Caucasian v. other), parity (continuous), gestational age at blood collection (continuous), 
previous live birth (yes/no), daughters’ preterm delivery (<37 weeks yes/no), birthweight 
(continuous, gm), breastfed (any v. none), activity level in childhood (very active v. not), exact 
age at DXA scan, and girls dietary energy and macronutrient intake at age 7 (continuous total 
energy, percent energy from fat, protein, and carbohydrate). None of these additional variables 
improved model fit or led to meaningful changes in the relationship between body fatness and 
PFCs; thus, they were not retained in the final models. Lastly, we considered potential effect 
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modification by maternal pre-pregnancy BMI, smoking and educational status by including these 
variables and their cross-product terms with each of the PFCs in their respective models. 




Table 1 presents sample demographic characteristics, median maternal prenatal PFC serum 
concentrations and median percent body fatness for daughters. Overall, the sample was 
primarily Caucasian (>90% of mothers and girls).  The majority (64%) of mothers were 
considered normal weight prior to pregnancy and nearly half of mothers reported a previous live 
birth. There were few girls who were preterm or of low birthweight. Of the PFCs measured, 
concentrations of PFOS were the highest (median 19.8; interquartile range (IQR) = 15.0–25.3 
ng/ml) and PFNA concentrations were the lowest (median 0.5; IQR = 0.4–0.7). Spearman 
correlation coefficients between the PFCs ranged between 0.25 for PFNA and PFHxS to 0.71 
for PFOA and PFOS (data not presented).  Median %BF for daughters was 27.5 (IQR = 21.7–
34.6).  
In multivariable regression analyses (Table 2) mothers’ PFCs were not associated with 
daughters’ %BF overall (main effects); however, we observed some differences in the 
associations between maternal PFC concentrations and daughters’ %BF by mothers’ 
educational status. Daughters’ %BF increased by 3% for each one unit increase in mothers 
PFHxS among girls with mothers in the highest and middle education groups, but was 
associated with a similar percent decrease among girls with mothers in the lowest education 
group.  A similar pattern of association was observed for PFOA with significant results only for 
the middle education group. There were no significant associations observed for PFOS. Lastly, 
among less-educated mothers, each one unit increase in PFNA was associated with a 12.7% 
increase in %BF among daughters. Mothers’ pre-pregnancy BMI and smoking status did not 
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significantly modify the associations between maternal PFC concentrations and daughters’ 
%BF.    
 
Discussion 
Our results suggest that prenatal exposure to some PFCs is associated with increased 
body fatness among this cohort of British girls but only after consideration of maternal education 
status.  Obesity is a multifactorial and complex disease and a number of dynamic genetic, 
environmental, lifestyle and social interactions likely contribute to its etiology (20). It is plausible 
that educational status is serving as a proxy for some other factor(s) that influence the 
associations between maternal PFC concentrations and %BF among daughters. For example, 
educational attainment is a well-known marker for socioeconomic status where disparities have 
been observed for maternal health-related behaviors and childhood obesity (21, 22). In addition, 
disparities may exist for exposures to PFCs.  In the early 1990’s when the ALSPAC prenatal 
blood collection took place, one important source of PFC exposure is thought to have occurred 
through contact with new furnishings and carpets in home and office settings; thus, participants 
of higher socioeconomic status might have experienced the highest exposures. Interestingly, 
concentrations of maternal PFCs in this data tend be positively associated with educational 
status (23-25). In this data, daughters of less educated (lower socioeconomic status) moms may 
have experienced more complex dynamic combinations of environmental, lifestyle and social 
stressors over time (20). Maternal education status is generally positively associated with diet 
quality during pregnancy and childhood but inversely associated with childhood obesity (22, 26). 
Families with more limited resources experience greater variability in some well-known 
contributors to childhood adiposity including diet composition, diet quality and acute and chronic 
food security which are challenging to measure accurately (i.e., self-reported) in epidemiologic 
research (27). This could at least in part contribute to the inconsistencies we observed by 
maternal educational status.  
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Previous observational epidemiologic studies that have examined the role of PFCs in 
childhood weight have yielded divergent results overall and within studies results have lacked 
consistency across the PFCs measured, not unlike the results in the current study. Andersen 
and colleagues (28) evaluated the role of prenatal exposure to PFOA and PFOS on measures 
of body fatness in 811 7-yr old children whose mothers participated in the Danish National Birth 
Cohort during 1996–2002. In contrast to the ALSPAC population, PFOA and PFOS plasma 
concentrations were not associated with lower weight in infancy in the Danish cohort (29).  
Similarly, maternal plasma PFCs were not significantly associated with BMI and waist 
circumference among 7-yr old girls or boys or in the group as a whole. It is noteworthy that both 
PFOA (median 5.3 ng/mL) and PFOS (median 33.8 ng/mL) concentrations were higher in 
Danish prenatal samples than we observed in ALSPAC (Table 1). Halldorsson et al. (30) 
assessed the association between prenatal PFC serum concentrations and weight among 665 
offspring (n=320 males; 345 females) of mothers recruited into the Aarhus Denmark birth cohort 
(1988-1989). Median maternal PFC concentrations in this study were similar to ours (Table 1): 
PFOA was 3.7 ng/mL, PFOS was 21.5 ng/mL, and PFNA was 0.3 ng/mL. In the Aarhus study 
maternal PFOA concentrations were positively and significantly associated with BMI and waist 
circumference among females at 20 years of age. Similar, but weaker, associations were 
observed for PFOS and PFNA among girls. None of the PFCs were associated with BMI or 
waist circumference among males (30).  Heyer et al. (31) analyzed PFOA and PFOS from the 
sera of 1022 pregnant women from Greenland and the Ukraine enrolled in the INUENODO 
cohort between 2002–2004. Median concentrations of maternal PFOA and PFOS were higher 
among the Greenland sample, (median PFOA=1.8 ng/mL; median PFOS 20.2 ng/mL) and more 
similar to our population (Table 1), than those from the Ukraine sample (median PFOA=1.0 
ng/mL; median PFOS=5.0 ng/mL).  The investigators reported adjusted relative risk (RR (95% 
CI)) of offspring overweight (defined as >85 percentile for age and sex) and unfavorable 
offspring waist-to-height ratio (>0.5) for continuous (natural log transformed) and tertiles of 
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PFCs between ages 5–9 years.  In country-specific and in pooled analyses, neither PFOA nor 
PFOS was significantly associated with offspring risk of overweight (31).  In the pooled analysis, 
continuous PFOS concentration was positively associated with offspring waist-to-height ratio 
(RR=1.38; CI=1.05-1.82); however, in gender-stratified analyses results were statistically 
significant only for girls (RR=1.54; CI=1.06-2.23) and not boys (RR=1.24; CI=0.82-1.87). There 
were no statistically significant findings for the association of tertiles of maternal PFCs with 
youth waist-to-height ratios (31).  Lastly, in the Cincinnati-based HOME Study, Braun and 
colleagues (32) evaluated associations of prenatal PFC concentrations (PFOA, PFOS, PFHxS 
and PFNA) with BMI, waist circumference, and percent body fat (measured by a Tanita body fat 
monitor) among a modestly sized sample of 8-year old children of both genders (n=204). 
Median prenatal PFOA concentration in HOME was 5.3 ng/mL, more than 1.5 times as high as 
in our population (median 3.7 ng/mL). This study reported positive associations between PFOA 
and BMI z-score trajectories, waist circumference and percent body fat. Results were not 
reported by gender; however, the results stated that gender did not modify the associations. No 
associations were observed for the other PFCs measured (PFOS, PFHxS and PFNA). The 
investigators noted that their study was limited by the use of less-refined measures of body 
fatness and that future studies should take advantage of more comprehensive measures such 
as DXA (32).    
In a recent review, Vandenberg and colleagues (33) discuss mechanisms for a variety of 
observed responses to low dose exposure to endocrine disrupting chemicals. Prenatal PFC 
exposure might influence childhood body fatness among girls through a number of potential 
mechanisms (3, 5, 34). According to a recent Scientific Statement on Endocrine-Disrupting 
Chemicals (EDCs) issued by the Endocrine Society (35), EDCs have broad effects on 
numerous endocrine endpoints in vivo and may act through an array of mechanisms including 
actions on estrogen and androgen receptors and through thyroid effects. In animal models, a 
growing body of research suggests that exposure to EDCs can increase the number and size of 
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adipocytes, alter insulin metabolism, and disrupt energy balance (36). While the molecular 
mechanisms involved are unclear, some research suggests that EDCs can interfere with 
epigenetic programming of gene regulation through activation of fat-regulating nuclear receptors 
like peroxisome proliferator-activated receptor gamma, which can lead to weight gain (37-39).  
Other potential mechanisms could include effects on neurocognitive development that could 
alter the processing of sensory information related to ingestive behaviors throughout life (40).         
There are a number of strengths to our analyses. All the data for the present study were 
collected prospectively by trained staff under tightly controlled conditions. PFCs were measured 
at the National Center for Environmental Health laboratories of the CDC, the laboratory that 
measures PFCs for NHANES. Concentrations of PFCs in the prenatal samples in our study are 
similar to those reported in recent analysis of samples from the 2009–2010 NHANES; thus, our 
results are potentially of relevance to current U.S. populations. Body fatness (composition) was 
measured by DXA which provides a more accurate estimate of fat mass than BMI or waist 
circumference (41). There are also some potential limitations. PFCs were measured only once 
during pregnancy and daughters’ PFC concentrations measured postnatally are not available. 
Generalizability of our findings was reduced by the demographic characteristics (mainly 
Caucasian) and geography (only UK) of our cohort. However, concentrations of PFCs in the 
prenatal samples in our study are similar to those reported in the United States in the 2009–
2010 NHANES (42). Our analyses were conducted on a sample of mother-daughter dyads 
selected for an ancillary study of pubertal development; weighted linear regression models were 
used to adjust for the sampling scheme. A subset of the daughters included in the ancillary 
study completed DXA scans for the assessment of body fatness. If the girls included in our 
analyses were not representative of all ancillary study participants or of the parent study then 
our results could be biased. However, we do not believe that selection bias played an important 
role in our findings. As reported previously, maternal characteristics for girls included in the 
ancillary sample were similar to the group of girls enrolled in the cohort (12) and based on the 
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available data for characteristics of mothers and daughters, our sample with complete data for 
both prenatal PFCs and youth DXA scans was representative of the overall ancillary sample. 
Finally, similar to previous investigations, our results do not show a consistent pattern of 
association across the PFCs measured. 
 
Conclusions 
In conclusion, in this British cohort we did not observe an overall association between maternal 
PFC exposure and %BF among girls.Prenatal exposure to some PFCs was associated with 
increased body fatness among girls, but only after consideration of maternal education status.. 
The role of environmental chemicals, like PFCs, in the development of overweight and obesity 
at different life stages is an important topic of emerging research and these results warrant 





Table 1. Sample Characteristics for Mothers of Girls and Girls at 9 Years of Age with 
PFCs and DXA (n=359) 
Variable N Median IQR 
PFOA (ng/ml) 359 3.7 (2.9, 4.8) 
PFOS (ng/ml) 359 19.8 (15.0, 25.3) 
PFHxS  (ng/ml) 359 1.6 (1.3, 2.2) 
PFNA (ng/ml) 358 0.5 (0.4,0.7) 
    
Gestational age at blood collection 
(wks.) 
359 15 (10, 28) 
    
Maternal age at collection (yrs.) 359 28.8 (25.6,32.1) 
    
Girls DXA-derived body fat at age 9 
(%) 
359 27.5 (21.7, 34.6) 
    
Girls BMI Z-Score at age 9 328 0.68 (-0.06,1.47) 
    
Girls dietary intake at age 7 340   
  Energy (kcal)  1649 (1426, 1857) 
  Fat (% energy)  36.7 (33.5, 39.7) 
  Carbohydrate (%  energy)  53.5 (50.0, 57.1) 
  Protein (% energy)  13.0 (11.5, 14.5) 
    
Variable N % 
Maternal prepregnancy BMI (kg/m2)   
 Underweight (<18.5) 16 4 
 Normal (18.5-24.9) 229 64 
 Overweight (25-29.9) 54 15 
 Obese (>30) 25 7 
 Missing 35 10 
   
Maternal education   
  Low 61 16 
  Medium 115 32 
  High 170 47 
  Missing 13 4 
   
Maternal race / Girls’ race   
 Caucasian 336 / 332 94 / 92 
 Other 10 / 13 3 / 4 
 Missing 13 / 14 4 / 4 
   
maternal smoking (#, % any prenatal) 72 20 
   
Previous life birth (#, % yes) 176 49 
Preterm delivery (#, % < 37 wks.) 12 3 
Low birth weight (#, % <2500 grams) 15 4 
Breastfed (#, % any) 278 77 
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Girls activity level (#, % very active) 173 48 
   
Menarche by age 9 (#, %yes) 4 1.1 
 
 
Table 2. Regression coefficients (β) for the relationship between perfluoroalkyl 
compounds and DXA-derived total body fatness (%) overall and by educational status 
(low, medium, high) 
Analyte β 95% CI p-value 
    
PFOS (ng/ml)    
   Overall** -0.07 -0.16, 0.02 0.12 
    Low Education 0.02 -0.18, 0.22 0.81 
    Medium  0.07 -0.20, 0.33 0.62 
    High -0.21 -0.45, 0.02 0.08 
    
PFOA (ng/ml)    
   Overall** -0.30 -0.76, 0.16 0.20 
    Low Education -1.03 -2.35, 0.29 0.13 
    Medium  2.44 0.68, 4.20 0.007 
    High 0.45 -0.97, 1.87 0.54 
    
PFHxS (ng/ml)    
   Overall** -0.06 -0.21, 0.09 0.47 
    Low Education -3.09 -6.04, -0.13 0.04 
    Medium  3.26 0.28, 6.24 0.03 
    High 3.00 0.04, 5.96 0.04 
    
PFNA (ng/ml)    
   Overall** 1.71 -1.29, 4.71 0.26 
    Low Education 12.73 0.11, 25.36 0.04 
    Medium  -9.30 -22.91, 4.31 0.18 
    High -12.61 -25.67, 0.45 0.06 
    
*Models adjusted for sampling design, prepregnancy body mass index (BMI kg/m2) and 
maternal educational status.  PFNA models were also adjusted for maternal smoking status.  
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